Results of Annual General Meeting and AGM Statement

                                                                                                                                    24 September 2013
("Sutherland Health Group" or "the Company")
The Board of Sutherland Health Group plc, a national supplier of patient hygiene, sexual health and diagnostic products to customers including the NHS announces that at the Company's Annual General Meeting held earlier today all Resolutions were duly passed.

John French Chairman provided the following statement:

"We are of course pleased with the performance of the company and encouraged by the continuing relationship with the NHS in addition to the continuing expansion of our relationships with major wholesalers taking it as it does into wider arena of customers.

In May by way of a placing of 8,000,000 new shares the company secured £100,000 of working capital to support the on-going development of the business. George Sutherland our Chief Executive subscribed for 300,000 of the new shares issued.

We continue to look for opportunities to further enhance the range of products we have on offer through the development of our own products and by the acquisition of products by way of distribution.

Earlier this month we announced the signing of an agreement with Lansinoh Laboratories Inc. to supply the Lansinoh range of breast feeding products to the UK medical market that has seen a significant rise in annual births in recent years to in excess of 800,000 births per annum.

The company has identified a number of similar opportunities and will be seeking to capitalise on such opportunities as appropriate."

The Directors of the Issuer accept responsibility for this announcement.

For further information:

John French, Chairman
Sutherland Health Group plc
T: 07836 722 482

Ross Andrews
Andrew Jones
Zeus Capital Ltd
T: 0161 831 1512

Notes to Editors:

Sutherland Health Group Plc is a national supplier of personal care; patient hygiene, sexualhealth and diagnostic products to the UK National Health Service (NHS) andother UK customers. Its aim is to supply innovative solutions to current healthissues by studying current trends and working alongside leading professionalswho also work within the health sector.

The company is committed to developing and marketing high quality brands and products that will benefit health professionals and consumers alike in manyareas of health. The Group has established its own brands: Condomania® Condoms;Sutherland® Patient Hygiene and Personal Care; Lubricating Jelly; and Vision®pregnancy and gynaecology diagnostics. These products have already becomeestablished within the NHS business.

The Group is ISO and MHRA registered, and at present principally manufactures and operates within the United Kingdom.

For further information on the Company visit

Latest news RSS


Sutherland at Procurex Wales 2017

Sutherland at Procurex Wales 2017


Final Results 30th September 2016

Sutherland Health Group Final Results September 2016


Sutherland Attending European Midwives Conference

Sutherland Attending EMA Conference

Sign up


For further information, please read our Privacy Policy.